Drug Shortage Report for ALKERAN

Last updated on 2021-11-05 History
Report ID 118933
Drug Identification Number 02087286
Brand name ALKERAN
Common or Proper name Alkeran Injection / Melphalan
Company Name ASPEN PHARMACARE CANADA INC.
Market Status MARKETED
Active Ingredient(s) MELPHALAN BUFFER SOLUTION
Strength(s) 50MG 10ML
Dosage form(s) KIT POWDER FOR SOLUTION SOLUTION
Route of administration INTRAVENOUS INTRA-ARTERIAL INTRA-ARTERIAL INTRAVENOUS
Packaging size 1 vial
ATC code L01AA
ATC description ALKYLATINGAGENTS
Reason for shortage Disruption of the manufacture of the drug.
Anticipated start date
Actual start date 2021-04-30
Estimated end date 2021-12-01
Actual end date 2021-11-04
Shortage status Resolved
Updated date 2021-11-05
Company comments GR80016CA1
Health Canada comments
Tier 3 Status No
Contact Address UNIT 8, 1155 NORTH SERVICE ROAD WEST
OAKVILLE, ONTARIO
CANADA L6M 3E3
Company contact information

Version History

Click on "Compare" below to view the full report history and compare to other versions.

Version Number Date Updated Language
v1 2020-06-25 English Compare
v2 2020-06-25 French Compare
v3 2020-07-22 English Compare
v4 2020-07-22 French Compare
v5 2020-07-22 English Compare
v6 2020-07-22 French Compare
v7 2020-07-23 English Compare
v8 2020-07-31 English Compare
v9 2020-07-31 French Compare
v10 2021-02-02 English Compare
v11 2021-03-24 English Compare
v12 2021-03-24 French Compare
v13 2021-03-24 English Compare
v14 2021-03-24 French Compare
v15 2021-05-01 English Compare
v16 2021-09-03 English Compare
v17 2021-09-03 French Compare
v18 2021-09-14 English Compare
v19 2021-09-14 English Compare
v20 2021-09-14 French Compare

Showing 1 to 20 of 29